Attendees

10 people attended the meeting.

Notes

The following points were raised:

Broadening membership

• The ISCET website currently does not appear in Google search results. Consider purchasing a domain to increase exposure, and using search engine optimisation.

• Sending the survey to individual clinicians is likely to increase ISCET's exposure

• Some specific contacts were suggested to spread the message, including neurologists and a representative from Apple

• Forming a board of directors now would increase visibility

Survey of current clinical eye tracker use

• Discussed whether the planned survey (which aims to understand current international clinical eye tracker usage) should solicit a single response from each professional body, or if it should seek individual responses from members of those societies.

  • In favour of only getting one response from each professional body:

    • Simplifies statistical analysis (dealing with disproportionate numbers of responses from each discipline)

    • Different privacy policies for each professional body may make it difficult to reach some members directly – could bias the results?

  • In favour of soliciting responses from individual members of each professional body:

    • More likely to pick up individual usage of eye trackers, even if the practice is not recognised formally by the professional body

    • Increases engagement with ISCET

• Consider whether funding bodies should be surveyed (as they interact with clinical researchers)

• To identify more professional bodies, ISCET should contact more clinician-researchers

• A template email will need to be produced to contact professional bodies

• Results of the survey planned to be written up as a group paper

Organising committee

• Only a few roles required at present:

  • General co-ordinator

  • Vice-president for each of the three geographical regions

  • Communications secretary

  • Unsure on best terminology to use for committee roles – MJD suggests avoiding titles that imply top-down decision making

• In time, the following roles will become relevant:

  • Treasurer

  • Membership secretary

  • Representatives for each of the clinical disciplines that ISCET serves

  • Manufacturer representative (this role may need to rotate regularly to avoid conflict of interest)

• People in committee roles initially could be for a short period only (until there is enough membership to formally vote for committee members)

• Early career individuals to be prioritised at this stage for committee membership

• Robert Alexander opted to take on role of vice president for the Americas, and Matt Dunn will continue with overall coordination. Still seeking people to fill other roles; all initial roles will be temporary until membership is broad enough for formal committees to be voted in.

Other points

• Care should be taken if including manufacturers and regulatory bodies in the development of standards, as there could be a conflict of interest. ISCET will need to determine how to handle conflicts of interest and competing viewpoints.

• ISCET should consider whether guidance needs to be given on the use of consumer eye tracking devices for clinical purposes

  • However, if ISCET standards define minimum requirements, it is then up to manufacturers to meet that standard if they want to be ISCET-compliant

• The group agreed the mission statement.

• Should a representative from the FDA be involved?

• Should ISCET be pushing for eye tracking tests to be given 'codes' (to allow clinicians in the US to formally charge for them)?

Next meeting

Items raised for the next meeting agenda:

• How can ISCET include input from manufacturers and regulators without undue bias due to conflicts of interest?

• Continuing to identify committee members

Chat